Compugen Second Quarter 2018 Conference Call Scheduled for Wednesday, August 1, 2018 at 8:30 AM ET

Wednesday, July 18, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

HOLON, Israel, July 18, 2018 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy

company and a leader in predictive target discovery, announced today that the Company will release its second quarter 2018 financial results on Wednesday, August 1, 2018 before the U.S. financial markets open. Management
will host a live webcast to review the results and provide a corporate update at 8:30 AM ET (please note new time for conference call).

To access the live conference call by telephone, please dial 1-888-668-9141 from the U.S., or +972-3-918-0609 internationally. The call will also be available via live webcast through Compugen's website, located at the following link. Following the live audio webcast, a replay will be available on the Company's website.

About CompugenCompugen is a clinical-stage, therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. Compugen's business model is to selectively enter into collaborations for its novel targets and related drug product candidates at various stages of research and development. The Company is headquartered in Israel with R&D facilities in both Israel and South San Francisco, CA. Compugen's ordinary shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For additional information, please visit Compugen's corporate website at www.cgen.com.

Company contact:Elana HolzmanDirector, Investor Relations and Corporate CommunicationsCompugen Ltd.Email: elanah@cgen.comTel: +972 (3) 765-8124

Investor Relations contact:Burns McClellan, Inc.Jill SteierEmail: jsteier@burnsmc.com Tel: 212-213-0006

Cision View original content:http://www.prnewswire.com/news-releases/compugen-second-quarter-2018-conference-call-scheduled-for-wednesday-august-1-2018-at-830-am-et-300682807.html

SOURCE Compugen Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store